U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Guidelines and Recommendations

CDC Stacks Public Health Publications

CDC Guidelines and Recommendations are updated by various CDC centers and institutes in response to new scientific discoveries, to public health issues, and to disease outbreaks. Items in this collection may have been superceded or replaced. For the most up to date information, please visit the CDC home page at https://www.cdc.gov/ and search the Health Topic or Outbreak you are interested in.

(5)
(2)
(4)
(3)
(2)
(3)
(17)
(10)
(16)
(13)
(27)
(33)
(21)
(46)
(33)
(34)
(34)
(22)
(25)
(18)
(19)
(27)
(21)
(29)
(13)
(15)
(17)
(14)
(12)
(10)
(13)
(15)
(12)
(14)
(11)
(16)
(16)
(6)
(1)
(3)
(3)
(6)
(3)
(1)
(4)
(27)
(22)
(30)
(8)
(9)
(7)
(7)
0 of 52
(123)
(27)
(1)
(1)
(626)
0 of 5
(1)
(1)
(3)
(2)
(1)
(30)
(1)
(7)
(1)
(3)
(7)
(1)
(1)
(1)
(104)
(1)
(1)
(7)
(3)
(2)
(1)
(1)
(45)
(1)
(117)
(8)
(51)
(2)
(29)
(5)
(4)
(1)
(1)
(1)
(2)
(413)
(2)
(5)
(13)
(2)
(1)
0 of 41
(7)
(2)
(39)
(3)
(2)
(2)
(7)
0 of 7
(53)
(6)
(5)
(1)
(3)
(12)
(563)
(1)
(1)
(22)
(41)
(63)
0 of 12
(449)
(1)
(31)
(270)
(1)
0 of 5
(130)
(18)
0 of 2
(138)
(9)
(1)
0 of 3
(2)
(1)
(9)
(8)
(6)
(2)
(1)
(1)
(1)
(1)
(14)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(2)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(2)
(2)
(74)
(1)
(5)
(1)
(1)
(1)
(87)
(1)
(1)
(7)
(1)
(4)
(35)
(2)
(9)
(1)
(5)
(2)
(1)
(8)
(3)
(3)
(7)
(1)
(2)
(1)
(1)
(2)
(2)
(2)
(29)
(1)
(8)
(20)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(36)
(6)
(1)
(6)
(3)
(13)
(2)
(2)
(1)
(5)
(1)
(1)
(2)
(1)
(8)
(1)
(2)
(1)
(8)
(1)
(3)
(3)
(1)
(8)
(5)
(1)
(1)
(2)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(14)
(3)
(4)
(1)
(2)
(1)
(3)
(6)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(2)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(6)
(10)
(1)
(10)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(8)
(1)
(1)
(1)
(4)
(2)
(4)
(9)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(2)
(6)
(1)
(3)
(1)
(3)
(1)
(2)
(13)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(22)
(2)
(13)
(3)
(1)
(2)
(1)
(4)
(2)
(4)
(1)
(1)
(1)
(4)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(6)
(3)
(1)
(1)
(1)
(3)
(3)
(1)
(1)
(6)
(2)
(2)
(1)
(91)
(76)
(3)
(1)
(1)
(1)
(2)
(4)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(11)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(3)
(3)
(2)
(2)
(6)
(2)
(3)
(9)
(2)
(5)
(2)
(3)
(4)
(14)
(3)
(2)
(10)
(4)
(3)
(4)
(3)
(4)
(6)
(2)
(2)
(2)
(2)
(11)
(2)
(2)
(10)
(3)
(2)
(4)
(4)
(5)
(3)
(2)
(2)
(2)
(11)
(10)
(2)
(15)
(6)
(3)
(3)
(2)
(3)
(2)
(5)
(3)
(3)
(2)
(7)
(2)
(2)
(2)
(3)
(3)
(2)
(8)
(5)
(2)
(2)
(2)
(2)
(2)
(3)
(10)
(10)
(2)
(2)
(2)
(3)
(2)
(15)
(2)
(4)
(2)
(6)
(24)
(20)
(18)
(2)
(5)
(2)
(7)
(3)
(2)
(5)
(8)
(2)
(2)
(3)
(7)
(2)
(2)
(5)
(3)
(9)
(11)
(2)
(3)
(2)
(2)
(4)
(4)
(6)
(2)
(2)
(2)
(2)
(4)
(3)
(2)
(25)
(2)
(15)
(2)
(3)
(5)
(31)
(2)
(2)
(5)
(2)
(3)
(15)
(2)
(3)
(5)
(4)
(7)
(2)
(2)
(2)
(4)
(4)
(6)
(3)
(5)
(2)
(3)
(3)
(4)
(64)
(2)
(2)
(3)
(2)
(3)
(2)
(2)
(2)
(4)
(3)
(2)
(3)
(4)
(2)
(3)
(2)
(2)
(2)
(4)
(2)
(4)
(2)
(3)
(3)
(2)
(2)
(2)
(3)
(13)
(8)
(2)
(77)
(3)
(10)
(7)
(3)
(4)
(21)
(2)
(3)
(5)
(13)
(4)
(2)
(2)
(2)
(3)
(3)
(2)
(2)
(4)
(4)
(2)
(5)
(3)
(3)
(3)
(2)
(4)
(2)
(8)
(4)
(2)
(2)
(8)
(4)
(5)
(2)
(2)
(2)
(2)
(9)
(7)
(6)
(2)
(3)
(3)
(43)
(2)
(3)
(2)
(4)
(2)
(5)
(2)
(2)
(11)
(11)
(6)
(4)
(6)
(6)
(6)
(2)
(2)
(2)
(5)
(221)
(12)
(2)
(2)
(2)
(2)
(10)
(7)
(2)
(18)
(2)
(2)
(7)
(7)
(4)
(9)
(98)
(2)
(2)
(10)
(2)
(2)
(4)
(2)
(3)
(5)
(83)
(30)
(2)
(31)
(7)
(2)
(8)
(2)
(7)
(3)
(4)
(5)
(20)
(10)
(9)
(3)
(14)
(6)
(2)
(12)
(4)
(11)
(2)
(10)
(2)
(16)
(5)
(2)
(2)
(21)
(18)
(3)
(8)
(3)
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(3)
(5)
(3)
(3)
(5)
(2)
(2)
(10)
(2)
(5)
(12)
(2)
(5)
(2)
(3)
(2)
(14)
(3)
(3)
(3)
(3)
(3)
(2)
(5)
(2)
(4)
(2)
(2)
(13)
(3)
(4)
(4)
(11)
(11)
(2)
(42)
(4)
(28)
(2)
(2)
(16)
(3)
(9)
(5)
(8)
(9)
(2)
(2)
(9)
(15)
(2)
(11)
(7)
(2)
(2)
(2)
(3)
(43)
(2)
(6)
(4)
(2)
(4)
(8)
(8)
(8)
(5)
(2)
(9)
(6)
(7)
(2)
(4)
(3)
(6)
(2)
(2)
(27)
(2)
(140)
(164)
(2)
(4)
(3)
(2)
(2)
(5)
(4)
(4)
(10)
(4)
(11)
(5)
(6)
(5)
(2)
(2)
(35)
(5)
(3)
(2)
(2)
(4)
(2)
(4)
(4)
(10)
(3)
(2)
(4)
(2)
(11)
(2)
(2)
(5)
(2)
(3)
(5)
(23)
(3)
(6)
(2)
(2)
(3)
(2)
(22)
(6)
(3)
(60)
(3)
(23)
(2)
(4)
(5)
(2)
(2)
(2)
(6)
(2)
(2)
(2)
(15)
(2)
(2)
(2)
(6)
(2)
(12)
(2)
(14)
(5)
(5)
(4)
(4)
(3)
(18)
(9)
(3)
(2)
(2)
(2)
(2)
(2)
(2)
(7)
(3)
(2)
(18)
(2)
(2)
(16)
(3)
(3)
(10)
(2)
(6)
(2)
(7)
(3)
(2)
(3)
(5)
(7)
(10)
(2)
(18)
(22)
(5)
(3)
(2)
(7)
(12)
(29)
(41)
(3)
(4)
(2)
(2)
(2)
(3)
(2)
(3)
(5)
(165)
(23)
(7)
(3)
(3)
(10)
(2)
(6)
(2)
(2)
(3)
(2)
(6)
(4)
(6)
(2)
(2)
(2)
(2)
(17)
(3)
(4)
(2)
(5)
(3)
(2)
(2)
(7)
(3)
(2)
(13)
(5)
(6)
(2)
(4)
(2)
(2)
(2)
(2)
(4)
(19)
(15)
(7)
(3)
(6)
(4)
(3)
(2)
(3)
(3)
(3)
(2)
(4)
(2)
(2)
(2)
(2)
(5)
(3)
(2)
(3)
(5)
(3)
(2)
(2)
(2)
(4)
(4)
(6)
(3)
(3)
(2)
(2)
(6)
(2)
(2)
(2)
(36)
(2)
(2)
(14)
(2)
(2)
(2)
(8)
(19)
(3)
(5)
(4)
(2)
(4)
(6)
(2)
(2)
(2)
(3)
(3)
(3)
(2)
(6)
(10)
(87)
(2)
(23)
(15)
(2)
(8)
(16)
(11)
(11)
(15)
(2)
(12)
(2)
(3)
(3)
(5)
(14)
(3)
(2)
(2)
(6)
(4)
(3)
(4)
(8)
(6)
(3)
(4)
(2)
(2)
(10)
(3)
(2)
(2)
(3)
(9)
(2)
(11)
(4)
(5)
(2)
(2)
(2)
(2)
(2)
(17)
(5)
(4)
(3)
0 of 1000
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(8)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(13)
(1)
(1)
(10)
(1)
(1)
(1)
(2)
(1)
(11)
(1)
(1)
(3)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(4)
(1)
(1)
(2)
(1)
(1)
(2)
(5)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(6)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(1)
(1)
(2)
(5)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(22)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(2)
(1)
(4)
(1)
(9)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(10)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(2)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(4)
(1)
(2)
(2)
(1)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(8)
(1)
(2)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(2)
(1)
(3)
(5)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(2)
(2)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(4)
(2)
(1)
(2)
(3)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(5)
(1)
(4)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(3)
(4)
(1)
(7)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(7)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(1)
(2)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(5)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(5)
(1)
(1)
(2)
(1)
(1)
(4)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(3)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(3)
(4)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(2)
(2)
(1)
(3)
(1)
(1)
(3)
(6)
(2)
(2)
(2)
(7)
(2)
(5)
(3)
(4)
(3)
(2)
(7)
(2)
(2)
(5)
(2)
(2)
(5)
(2)
(2)
(3)
(3)
(3)
(3)
(3)
(4)
(2)
(5)
(3)
(4)
(2)
(2)
(2)
(2)
(2)
(2)
(5)
(9)
(2)
(3)
(2)
(2)
(2)
(2)
(2)
(7)
(3)
(2)
(6)
(2)
(2)
(2)
(3)
(2)
(3)
(2)
(6)
(4)
(2)
(5)
(5)
(8)
(2)
(2)
(4)
(3)
(3)
0 of 1000
(1)
(6)
(1)
(1)
(3)
(19)
(1)
(3)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(12)
(17)
(8)
(1)
(2)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(4)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(26)
(1)
(2)
(1)
(1)
(4)
(22)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(276)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(6)
(1)
(1)
(4)
(1)
(1)
(2)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(5)
(1)
(1)
(2)
(7)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(13)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(1)
(1)
(2)
(4)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(11)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(3)
(2)
(1)
(1)
(3)
(1)
(4)
(2)
(4)
(5)
(2)
(5)
(2)
(3)
(1)
(22)
(1)
(3)
(1)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(8)
(1)
(1)
(2)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(5)
(1)
(1)
(1)
(1)
(10)
(1)
(3)
(1)
(4)
(4)
(4)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(7)
(6)
(4)
(9)
(18)
(1)
(2)
(1)
(1)
(1)
(4)
(6)
(1)
(1)
(4)
(3)
(1)
(1)
(1)
(4)
(1)
(1)
(15)
(6)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(2)
(1)
(1)
(4)
(1)
(2)
(1)
(8)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(6)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(1)
(8)
(3)
(7)
(1)
(1)
(144)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(8)
(1)
(3)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(1)
(3)
(12)
(122)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(4)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(9)
(1)
(1)
(3)
(1)
(1)
(1)
0 of 444
(1)
(1)
(9)
(4)
(1)
(1)
(2)
(89)
(3)
(2)
(40)
(230)
(1)
(25)
(1)
(81)
(1)
(26)
(2)
(4)
(146)
(1)
(1)
(4)
(1)
(4)
0 of 26
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
0 of 171
Showing 541 - 560 of 779 results
  • Morbidity and Mortality Weekly Report Recommendations and Reports June 16 1995 Vol 44 No RR5
    Morbidity and Mortality Weekly Report: Recommendations and Reports, June 16, 1995 / Vol. 44 / No. RR-5
    Gindler, Jacqueline S. ;
    Hadler, Stephen C.
    June 16, 1995 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    The need for a single childhood immunization schedule prompted the unification of previous vaccine recommendations made by the American Academy of Pediatrics (AAP) and the Advisory Committee on Immunization Practices (ACIP). In addition to presenting the newly recommended schedule for the administration of vaccines during childhood, this report add ...
    Superseded Public Domain
  • TB infection control recommendations from the CDC 1994 considerations for dentistry
    TB infection control recommendations from the CDC, 1994 : considerations for dentistry
    National Center for Prevention Services (U.S.). Division of Oral Health.
    May 1995 | Journal of the American Dental Association (1939). 1995; 126(5):593-9.
    Between 1989 and 1992, reports of outbreaks and transmissions of tuberculosis in institutional settings prompted the Centers for Disease Control and Prevention to review the guidelines for TB infection control it had published in 1990. The CDC published an updated version of the guidelines in October 1994. This article gives dentists an overview of ...
    Retired Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports April 21 1995 Vol 44 No RR3
    Morbidity and Mortality Weekly Report: Recommendations and Reports, April 21, 1995 / Vol. 44 / No. RR-3
    Arden, Nancy H. ;
    Cox, Nancy (Nancy J.)
    April 21, 1995 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    These recommendations update information on the vaccine and antiviral agents available for controlling influenza during the 1995-96 influenza season (superseding MMWR 1994;43(No. RR-9) 1-13 and MMWR 1994;43(No. RR-15): 1-10). The principal changes include information about a) the influenza virus strains included in the trivalent vaccine for 1995-96 ...
    Superseded Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports February 17 1995 Vol 44 No RR1
    Morbidity and Mortality Weekly Report: Recommendations and Reports, February 17, 1995 / Vol. 44 / No. RR-1
    Brewer, Robert D. ;
    Fenley, Mary Ann
    February 17, 1995 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    These recommendations on the use of bicycle helmets are the first in a series of Injury-Control Recommendations that are designed for state and local health departments or other organizations for use in planning injury control programs. Each publication in the series of Injury-Control Recommendations will provide information for program planners to ...
    Current Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports March 17 1995 Vol 44 No RR2
    Morbidity and Mortality Weekly Report: Recommendations and Reports, March 17, 1995 / Vol. 44 / No. RR-2
    National Association of State Public Health Veterinarians, Inc.
    March 17, 1995 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    The purpose of this Compendium is to provide rabies information to veterinarians, public health officials, and others concerned with rabies control. These recommendations serve as the basis for animal rabies-control programs throughout the United States and also facilitate standardization of procedures among jurisdictions, thereby contributing to a ...
    Superseded Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports December 30 1994 Vol 43 No RR15
    Morbidity and Mortality Weekly Report: Recommendations and Reports, December 30, 1994 / Vol. 43 / No. RR-15
    Arden, Nancy H. ;
    Cox, Nancy (Nancy J.)
    December 30, 1994 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    "These recommendations provide information about two antiviral agents: amantadine hydrochloride and rimantadine hydrochloride. These recommendations supersede MMWR 1992;41(No. RR-9). The primary changes include information about the recently licensed drug rimantadine, expanded information on the potential for adverse reactions to amantadine and rim ...
    Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports December 9 1994 Vol 43 No RR14
    Morbidity and Mortality Weekly Report: Recommendations and Reports, December 9, 1994 / Vol. 43 / No. RR-14
    Cieslak, Paul R. ;
    Tauxe, Robert V.
    December 9, 1994 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    "These revised recommendations of the Advisory Committee on Immunization Practices update previous recommendations (MMWR 1990;39[RR-10]:1-5). They include information on the Vi capsular polysaccharide (ViCPS) vaccine, which was not available when the previous recommendations were published." - p. 1Includes bibliographical references (p. 6-7).
    Current Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports October 28 1994 Vol 43 No RR13
    Morbidity and Mortality Weekly Report: Recommendations and Reports, October 28, 1994 / Vol. 43 / No. RR-13
    Bozzi, Carmine J. ;
    Burwen, Dale R.
    October 28, 1994 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    This document updates and replaces all previously published guidelines for the prevention of Mycobacterium tuberculosis transmission in health-care facilities. The purpose of this revision is to emphasize the importance of a) the hierarchy of control measures, including administrative and engineering controls and personal respiratory protection; b) ...
    Superseded Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports August 5 1994 Vol 43 No RR11
    Morbidity and Mortality Weekly Report: Recommendations and Reports, August 5, 1994 / Vol. 43 / No. RR-11
    Balsley, James ;
    Mofenson, Lynne
    August 5, 1994 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    These recommendations update the interim guidelines (1) developed by the U.S. Public Health Service for the use of zidovudine (ZDV) to reduce the risk for perinatal transmission of human immunodeficiency virus (HIV) infection. The recently reported results of AIDS Clinical Trials Group Protocol 076 demonstrated that ZDV administered to a selected g ...
    Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports June 17 1994 Vol 43 No RR10
    Morbidity and Mortality Weekly Report: Recommendations and Reports, June 17, 1994 / Vol. 43 / No. RR-10
    National Association of State Public Health Veterinarians, Inc.
    June 17, 1994 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    The purpose of this Compendium is to provide rabies information to veterinarians, public health officials, and others concerned with rabies control. These recommendations serve as the basis for animal rabies control programs throughout the United States and facilitate standardization of procedures among jurisdictions, thereby contributing to an eff ...
    Superseded Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports May 27 1994 Vol 43 No RR9
    Morbidity and Mortality Weekly Report: Recommendations and Reports, May 27, 1994 / Vol. 43 / No. RR-9
    Arden, Nancy H. ;
    Cox, Nancy (Nancy J.)
    May 27, 1994 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    These recommendations update information on the vaccine available for controlling influenza during the 1994-95 influenza season. The recommendations supersede MMWR 1993;42(No. RR-6)1-13. Antiviral agents also have an important role in the control of influenza. Recommendations for the use of antiviral agents will be published later in 1994 as Part I ...
    Superseded Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports May 20 1994 Vol 43 No RR8
    Morbidity and Mortality Weekly Report: Recommendations and Reports, May 20, 1994 / Vol. 43 / No. RR-8
    Rogers, Martha F. ;
    Simonds, Robert J.
    May 20, 1994 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    Although previous recommendations for preventing transmission of human immunodeficiency virus (HIV) through transplantation of human tissue and organs have markedly reduced the risk for this type of transmission, a case of HIV transmission from a screened, antibody-negative donor to several recipients raised questions about the need for additional ...
    Current Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports May 13 1994 Vol 43 No RR7
    Morbidity and Mortality Weekly Report: Recommendations and Reports, May 13, 1994 / Vol. 43 / No. RR-7
    Knudsen, Richard C. ;
    Mathews, Henry M.
    May 13, 1994 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    "This report provides interim biosafety guidelines for preventing laboratory-associated infections with agents that cause hantavirus pulmonary syndrome. The guidelines are based on extensive laboratory experience with the other hantaviruses--particularly work involving the use of permissive host animal species--and on the limited experience with a ...
    Current Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports February 25 1994 Vol 43 No RR2
    Morbidity and Mortality Weekly Report: Recommendations and Reports, February 25, 1994 / Vol. 43 / No. RR-2
    Centers for Disease Control and Prevention (U.S.)  ...
    February 25, 1994 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    Tobacco use is the leading cause of preventable death in the United States. The majority of daily smokers (82%) began smoking before 18 years of age, and more than 3,000 young persons begin smoking each day. School programs designed to prevent tobacco use could become one of the most effective strategies available to reduce tobacco use in the Unite ...
    Retired Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports April 22 1994 Vol 43 No RR6
    Morbidity and Mortality Weekly Report: Recommendations and Reports, April 22, 1994 / Vol. 43 / No. RR-6
    National Center for Injury Prevention and Control (U.S.). Division of Violence Prevention.
    April 22, 1994 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    Programs for the Prevention of Suicide among Adolescents and Young Adults: Incidence rates of suicide and attempted suicide among adolescents and young adults aged 15-24 years continue to remain at high levels. In 1992, to aid communities in developing new or augmenting existing suicide prevention programs directed toward this age group, CD''s Nati ...
    Superseded Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports March 4 1994 Vol 43 No RR3
    Morbidity and Mortality Weekly Report: Recommendations and Reports, March 4, 1994 / Vol. 43 / No. RR-3
    Nicholson, Janet K. A., 1948- ;
    McDougal, J. Steven
    March 4, 1994 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    The Food and Drug Administration (FDA) has recommended that all donated blood be screened for antibodies to human immunodeficiency virus type 2 (HIV-2) beginning no later than June 1, 1992. This article provides CDC recommendations for the DIAGNOSIS of HIV-1 and HIV-2 infections in persons being tested in settings other than blood centers and CDC/F ...
    Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports January 28 1994 Vol 43 No RR1
    Morbidity and Mortality Weekly Report: Recommendations and Reports, January 28, 1994 / Vol. 43 / No. RR-1
    Hadler, Stephen C. ;
    Hutchins, Sonja S.
    January 28, 1994 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    This revision of the General Recommendations on Immunization updates the 1989 statement. Changes in the immunization schedule for infants and children include recommendations that the third dose of oral polio vaccine be administered routinely at 6 months of age rather than at age 15 months and that measles-mumps-rubella vaccine be administered rout ...
    Public Domain
  • Guidelines for Designing Rapid Assessment Surveys of HIV Seroprevalence Among Hospitalized Patients
    Guidelines for Designing Rapid Assessment Surveys of HIV Seroprevalence Among Hospitalized Patients
    Schwartländer, B ;
    Janssen, R S
    1994 Jan-Feb | Public Health Rep. 1994 Jan-Feb;109(1):53-9.
    The Centers for Disease Control and Prevention has developed guidelines for determining HIV seroprevalence among patients seeking medical care at acute-care hospitals. The guidelines enable hospital staff members to perform a simple, rapid, and inexpensive survey to determine seroprevalence among the patient population, protecting the anonymity of ...
    Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports September 24 1993 Vol 42 No RR14
    Morbidity and Mortality Weekly Report: Recommendations and Reports, September 24, 1993 / Vol. 42 / No. RR-14
    Centers for Disease Control and Prevention (U.S.)
    September 24, 1993 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    These guidelines for the treatment of patients with sexually transmitted diseases (STDs) were developed by staff members of CDC after consultation with a group of invited experts who met in Atlanta on January 19–21, 1993. Included are new recommendations for single-dose oral therapy for gonococcal infections, chlamydial infections, and chancroid; n ...
    Superseded Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports September 17 1993 Vol 42 No RR13
    Morbidity and Mortality Weekly Report: Recommendations and Reports, September 17, 1993 / Vol. 42 / No. RR-13
    Zangwill, Kenneth M. ;
    Wenger, Jay D.
    September 17, 1993 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    These recommendations include information on two vaccines recently licensed for use among infants: Haemophilus b Conjugate Vaccine (PRP-T [ActHIB, OmniHIB]), manufactured by Pasteur M rieux Vaccins, and TETRAMUNE, manufactured by Lederle Laboratories/Praxis Biologics. This statement also updates recommendations for use of other available Haemophilu ...
    Current Public Domain
541 - 560 / 779